-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Institutional Investors Own a Significant Stake of 50% in Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)
Institutional Investors Own a Significant Stake of 50% in Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)
To get a sense of who is truly in control of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are institutions with 50% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait.
Let's take a closer look to see what the different types of shareholders can tell us about Guangzhou Kingmed Diagnostics Group.
Check out our latest analysis for Guangzhou Kingmed Diagnostics Group
SHSE:603882 Ownership Breakdown September 12th 2022What Does The Institutional Ownership Tell Us About Guangzhou Kingmed Diagnostics Group?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
As you can see, institutional investors have a fair amount of stake in Guangzhou Kingmed Diagnostics Group. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Guangzhou Kingmed Diagnostics Group's earnings history below. Of course, the future is what really matters.
SHSE:603882 Earnings and Revenue Growth September 12th 2022We note that hedge funds don't have a meaningful investment in Guangzhou Kingmed Diagnostics Group. The company's CEO Yaoming Liang is the largest shareholder with 16% of shares outstanding. With 7.7% and 5.2% of the shares outstanding respectively, Guangzhou Xinmanyu Investment Management Partnership Enterprise (Limited Partnership) and Guangzhou Shengboyu Investment Management Partnership Enterprise (Limited Partnership) are the second and third largest shareholders.
We did some more digging and found that 9 of the top shareholders account for roughly 50% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
Insider Ownership Of Guangzhou Kingmed Diagnostics Group
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
It seems insiders own a significant proportion of Guangzhou Kingmed Diagnostics Group Co., Ltd.. It is very interesting to see that insiders have a meaningful CN¥5.4b stake in this CN¥31b business. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.
General Public Ownership
The general public, who are usually individual investors, hold a 21% stake in Guangzhou Kingmed Diagnostics Group. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Private Equity Ownership
Private equity firms hold a 6.6% stake in Guangzhou Kingmed Diagnostics Group. This suggests they can be influential in key policy decisions. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.
Private Company Ownership
We can see that Private Companies own 5.2%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.
Next Steps:
While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - Guangzhou Kingmed Diagnostics Group has 3 warning signs (and 2 which are a bit concerning) we think you should know about.
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
要弄清楚誰真正控制了廣州金美德診斷集團有限公司(上證號:603882),瞭解企業的所有權結構是很重要的。而持有這塊蛋糕最大份額的是擁有50%股權的機構。換句話説,該集團面臨着最大的上行潛力(或下行風險)。
由於機構所有者擁有巨大的資源和流動性,他們的投資決策往往具有很大的份量,特別是對個人投資者來説。因此,擁有相當數量的機構資金投資於一家公司通常被視為一種可取的特徵。
讓我們仔細看看不同類型的股東能告訴我們關於廣州金美診斷集團的什麼。
查看我們對廣州金美診斷集團的最新分析
上海證交所:603882所有權明細2022年9月12日關於廣州金美診斷集團,機構持股告訴了我們什麼?
許多機構以一個接近當地市場的指數來衡量它們的表現。因此,他們通常更關注那些被納入主要指數的公司。
如你所見,機構投資者在廣州金美診斷集團持有相當數量的股份。這表明在專業投資者中有一定的可信度。但我們不能僅僅依靠這一事實,因為機構有時會做出糟糕的投資,就像每個人一樣。如果多家機構同時改變對一隻股票的看法,你可能會看到股價迅速下跌。因此,下面是廣州金美診斷集團的盈利歷史,值得一看。當然,未來才是真正重要的。
上海證交所:603882收益和收入增長2022年9月12日我們注意到,對衝基金沒有對廣州金美診斷集團進行有意義的投資。該公司首席執行官樑耀明是最大股東,持有16%的流通股。廣州新漫裕投資管理合夥企業(有限合夥)和廣州聖博裕投資管理合夥企業(有限合夥)分別持有7.7%和5.2%的流通股,為第二和第三大股東。
我們做了更多的挖掘,發現9個大股東約佔登記的50%,這意味着除了大股東外,還有一些小股東,從而在一定程度上平衡了彼此的利益。
研究機構持股是衡量和篩選股票預期表現的好方法。通過研究分析師的情緒,也可以達到同樣的效果。相當多的分析師追蹤這隻股票,所以你可以很容易地研究預測增長。
廣州金美德診斷集團的內部人所有權
儘管對內部人的準確定義可能是主觀的,但幾乎每個人都認為董事會成員是內部人。管理層最終要向董事會負責。然而,經理人擔任執行董事會成員並不少見,尤其是如果他們是創始人或首席執行官的話。
內部人持股是積極的,當它標誌着領導層像公司的真正所有者一樣思考時。然而,高內部人持股也可以給公司內部的一個小團體帶來巨大的權力。在某些情況下,這可能是負面的。
內部人士似乎持有廣州金美德診斷集團有限公司相當大的股份。非常有趣的是,看到內部人士在這筆CN元310億元的業務中持有有意義的CN元54億股份。大多數人會高興地看到董事會與他們一起投資。你可能希望訪問這張顯示內部人士最近交易的免費圖表。
一般公有制
公眾通常是個人投資者,他們持有廣州金美診斷集團21%的股份。儘管這種規模的所有權可能不足以影響有利於他們的政策決定,但他們仍然可以對公司政策產生集體影響。
私募股權所有權
私募股權公司持有廣州金美診斷集團6.6%的股份。這表明,他們可以在關鍵的政策決策中發揮影響力。一些人可能會喜歡這樣,因為私人股本有時是讓管理層承擔責任的積極分子。但在其他時候,私募股權公司讓公司上市後,它們的股票都賣光了。
私營公司所有權
我們可以看到,私營公司擁有5.2%的已發行股份。僅從這一事實很難得出任何結論,因此值得調查一下誰擁有這些私營公司。有時,內部人士或其他關聯方通過一家獨立的私人公司擁有上市公司的股份。
接下來的步驟:
雖然考慮擁有一家公司的不同集團是很值得的,但還有其他更重要的因素。以風險為例-廣州金美診斷集團3個警示標誌(和2個有點令人擔憂的問題)我們認為你應該知道。
如果你像我一樣,你可能會想一想這家公司是會增長還是會萎縮。幸運的是,您可以查看這份顯示分析師對其未來預測的免費報告。
注:本文中的數字是使用過去12個月的數據計算的,指的是截至財務報表日期的最後一個月的12個月期間。這可能與全年的年度報告數字不一致。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧